TG’s Follicular Lymphoma Data Suggest Umbralisib Could Succeed In PI3K Delta Class

Follicular lymphoma is one of mature B-cell neoplasm
TG Therapeutics hopes it can provide a safer, more tolerable follicular lymphoma therapy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D